First human tests begin for new breast cancer drug alternative
NCT ID NCT06995482
Summary
This early-stage study aims to check if a new drug called KSHN001034 is safe and behaves similarly in the body to an existing breast cancer medication. The study will involve 40 healthy postmenopausal women who will receive either the new drug or the existing one. Researchers will monitor for side effects and measure how the drug moves through the body over several weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY POSTMENOPAUSAL WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Floridian Clinical Research LLC
RECRUITINGMiami Lakes, Florida, 33016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Synergen Bio Pvt. Ltd.
RECRUITINGPune, Maharashtra, 411003, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.